TABLE 3b. Estimated percent for time since first diagnosis among adults1 with active2 asthma by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2011

Print
Related Pages
State/Territory Sample
size± 		5 or fewer years More than 5 years
Sample
size		 % SE§ 95% CI† Sample
size		 % SE 95% CI
Alabama 213 22 N/A N/A (N/A – N/A) 191 88.4 4.6 (79.4 – 97.4)
Arizona 252 35 N/A N/A (N/A – N/A) 217 86.1 4.4 (77.5 – 94.7)
California 536 73 15.8 2.6 (10.7 – 20.9) 463 84.2 2.6 (79.1 – 89.3)
Connecticut 279 36 12.5 3.1 (6.4 – 18.6) 243 87.5 3.1 (81.4 – 93.6)
District of Columbia 169 22 20.6 5.8 (9.2 – 32.0) 147 79.4 5.8 (68.0 – 90.8)
Florida 412 59 15.0 3.8 (7.6 – 22.4) 353 85.0 3.8 (77.6 – 92.4)
Georgia 272 46 13.9 3.8 (6.5 – 21.3) 226 86.1 3.8 (78.7 – 93.5)
Hawaii 256 38 N/A N/A (N/A – N/A) 218 86.4 4.2 (78.2 – 94.6)
Illinois 187 25 8.6 2.5 (3.7 – 13.5) 162 91.4 2.5 (86.5 – 96.3)
Indiana 342 57 21.8 4.0 (14.0 – 29.6) 285 78.2 4.0 (70.4 – 86.0)
Iowa 206 31 19.1 5.5 (8.3 – 29.9) 175 80.9 5.5 (70.1 – 91.7)
Kansas 761 109 14.4 2.2 (10.1 – 18.7) 652 85.6 2.2 (81.3 – 89.9)
Louisiana 285 44 11.8 3.0 (5.9 – 17.7) 241 88.2 3.0 (82.3 – 94.1)
Maine 295 33 14.2 3.7 (6.9 – 21.5) 262 85.8 3.7 (78.5 – 93.1)
Maryland 224 30 9.0 2.2 (4.7 – 13.3) 194 91.0 2.2 (86.7 – 95.3)
Massachusetts 243 27 N/A N/A (N/A – N/A) 216 91.3 3.5 (84.4 – 98.2)
Michigan 544 76 12.0 2.7 (6.7 – 17.3) 468 88.0 2.7 (82.7 – 93.3)
Mississippi 281 47 11.9 2.6 (6.8 – 17.0) 234 88.1 2.6 (83.0 – 93.2)
Missouri 222 40 11.0 2.5 (6.1 – 15.9) 182 89.0 2.5 (84.1 – 93.9)
Montana 357 42 N/A N/A (N/A – N/A) 315 88.2 3.8 (80.8 – 95.6)
Nebraska 723 93 15.7 3.0 (9.8 – 21.6) 630 84.3 3.0 (78.4 – 90.2)
Nevada 142 21 N/A N/A (N/A – N/A) 121 81.0 8.2 (64.9 – 97.1)
New Hampshire 240 36 9.9 2.2 (5.6 – 14.2) 204 90.1 2.2 (85.8 – 94.4)
New Jersey 368 69 19.0 3.9 (11.4 – 26.6) 299 81.0 3.9 (73.4 – 88.6)
New Mexico 339 43 11.2 3.2 (4.9 – 17.5) 296 88.8 3.2 (82.5 – 95.1)
New York 146 17 12.3 3.4 (5.6 – 19.0) 129 87.7 3.4 (81.0 – 94.4)
North Carolina 243 33 14.4 3.8 (7.0 – 21.8) 210 85.6 3.8 (78.2 – 93.0)
North Dakota 188 33 N/A N/A (N/A – N/A) 155 78.6 7.2 (64.5 – 92.7)
Ohio 335 56 12.2 2.4 (7.5 – 16.9) 279 87.8 2.4 (83.1 – 92.5)
Oklahoma 314 47 17.5 4.2 (9.3 – 25.7) 267 82.5 4.2 (74.3 – 90.7)
Oregon 200 25 10.7 3.1 (4.6 – 16.8) 175 89.3 3.1 (83.2 – 95.4)
Pennsylvania 412 57 16.4 3.6 (9.3 – 23.5) 355 83.6 3.6 (76.5 – 90.7)
Rhode Island 273 32 10.7 3.1 (4.6 – 16.8) 241 89.3 3.1 (83.2 – 95.4)
Texas 569 77 14.7 3.2 (8.4 – 21.0) 492 85.3 3.2 (79.0 – 91.6)
Utah 459 84 21.6 3.8 (14.2 – 29.0) 375 78.4 3.8 (71.0 – 85.8)
Vermont 317 42 17.9 4.1 (9.9 – 25.9) 275 82.1 4.1 (74.1 – 90.1)
Washington 676 70 12.6 2.4 (7.9 – 17.3) 606 87.4 2.4 (82.7 – 92.1)
West Virginia 202 25 7.8 1.9 (4.1 – 11.5) 177 92.2 1.9 (88.5 – 95.9)
Wisconsin 244 30 8.7 2.3 (4.2 – 13.2) 214 91.3 2.3 (86.8 – 95.8)
Puerto Rico 325 36 6.2 1.8 (2.7 – 9.7) 289 93.8 1.8 (90.3 – 97.3)
40 state total 13,051 1,818 13.7 0.7 (12.3 – 15.1) 11,233 86.3 0.7 (84.9 – 87.7)
Median     12.6       86.9    
Range     6.2-21.8       78.2-93.8    

1 Aged ≥ 18 years
2 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > .30